Reduction of caveolin-3 expression does not inhibit stretch-induced phosphorylation of ERK2 in skeletal muscle myotubes

Journal of Applied Physiology

Volumn 98, Issue 4, 2005, Pages 1554-1561

  Bellott, Anne Claire ^a,b   Patel, Kalpit C ^b   Burkholder, Thomas J ^b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Caveolae; Mechanotransduction; Mitogen activated protein kinase

Indexed keywords

CAVEOLIN 3; CHOLESTEROL; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; MECHANOTRANSDUCTION; MOUSE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE GROWTH; MUSCLE STRETCHING; MYOTUBE; NONHUMAN; OLIGOMERIZATION; POSTNATAL GROWTH; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SATELLITE CELL; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; VISCOELASTICITY;

ANIMALS; CAVEOLIN 3; CAVEOLINS; CELL LINE; CHOLESTEROL; GENE EXPRESSION REGULATION; MECHANOTRANSDUCTION, CELLULAR; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUSCLE FIBERS; MUSCLE, SKELETAL; PHOSPHORYLATION; PHYSICAL STIMULATION;

EID: 15444375974     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01070.2004     Document Type: Article

References (67)

1. Aronson D, Violan MA, Dufresne SD, Zangen D, Fielding RA, and Goodyear LJ. Exercise stimulates the mitogen-activated protein kinase pathway in human skeletal muscle. J Clin Invest 99: 1251-1257, 1997.
2. S6k correlates with increased skeletal muscle mass following resistance exercise. Am J Physiol Cell Physiol 276: C120-C127, 1999.
3. Boyd NL, Park H, Yi H, Boo YC, Sorescu GP, Sykes M, and Jo H. Chronic shear induces caveolae formation and alters ERK and Akt responses in endothelial cells. Am J Physiol Heart Circ Physiol 285: H1113-H1122, 2003.
4. Burkholder TJ. Permeability of C2C12 myotube membranes is influenced by stretch velocity. Biochem Biophys Res Commun 305: 266-270. 2003.
5. Burkholder TJ, Fingado B, Baron S, and Lieber RL. Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb. J Morphol 221: 177-190, 1994.
6. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, Panella A, Zara F, Bricarelli FD, Cordone G, Lisanti MP, and Minetti C. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 54: 1373-1376, 2000.
7. Carson JA and Wei L. Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle. J Appl Physiol 88: 337-343, 2000.
8. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, and McCubrey JA. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention. Leukemia 17: 1263-1293, 2003.
9. Clark CB, Burkholder TJ, and Frangos JA. Uniaxial strain system to investigate strain rate regulation in vitro. Rev Sci Instrum 272: 2415-2422, 2001.
10. Clarke MS, Khakee R, and McNeil PL. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 106: 121-133, 1993.
11. Dulhunty AF and Franzini-Armstrong C. The relative contributions of the folds and caveolae to the surface membrane of frog skeletal muscle fibres at different sarcomere lengths. J Physiol 250: 513-539, 1975.
12. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, and Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428: 205-211, 1998.
13. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H Jr, Kneitz B, Edelmann W, and Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities: J Biol Chem 276: 21425-21433, 2001.
14. Galbiati F, Volonte D, Chu JB, Li M, Fine SW, Fu M, Bermudez J, Pedemonte M, Weidenheim KM, Pestell RG, Minetti C, and Lisanti MP. Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci USA 97: 9689-9694, 2000.
15. Galbiati F, Volonte D, Engelman JA, Scherer PE, and Lisanti MP. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J Biol Chem 274: 30315-30321, 1999.
16. Galbiati F, Volonte D, Minetti C, Chu JB, and Lisanti MP. Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex. J Biol Chem 274: 25632-25641, 1999.
17. Goldspink G, Williams P, and Simpson H. Gene expression in response to muscle stretch. Clin Orthop 403, Suppl: S146-S152, 2002.
18. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, and Kikuchi T. Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 9: 3047-3054, 2000.
19. Huet de la Tour E, Tardieu C, Tabary JC, and Tabary C. Decrease of muscle extensibility and reduction of sarcomere number in soleus muscle following a local injection of tetanus toxin. J Neurol Sci 40: 123-131, 1979.
20. Jones NC, Fedorov YV, Rosenthal RS, and Olwin BB. ERK1/2 is required for myoblast proliferation but is dispensable for muscle gene expression and cell fusion. J Cell Physiol 186: 104-115, 2001.
21. Kawabe J, Okumura S, Lee MC, Sadoshima J, and Ishikawa Y. Translocation of caveolin regulates stretch-induced ERK activity in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 286: H1845-H1852, 2004.
22. Kawamura S, Miyamoto S, and Brown JH. Initiation and transduction of stretch-induced RhoA and Rac1 activation through caveolae: cytoskeletal regulation of ERK translocation. J Biol Chem 278: 31111-31117, 2003.
23. Koh TJ and Herzog W. Excursion is important in regulating sarcomere number in the growing rabbit tibialis anterior. J Physiol 508: 267-280, 1998.
24. Lexell J, Taylor CC, and Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 84: 275-294, 1988.
25. α subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
26. Loughna P, Goldspink G, and Goldspink DF. Effect of inactivity and passive stretch on protein turnover in phasic and postural rat muscles. J Appl Physiol 61: 173-179, 1986.
27. Lutz GJ and Rome LC. Built for jumping: the design of the frog muscular system. Science 263: 370-372, 1994.
28. Mack PJ, Kaazempur-Mofrad MR, Karcher H, Lee RT, and Kamm RD. Force-induced focal adhesion translocation: effects of force amplitude and frequency. Am J Physiol Cell Physiol 287: C954-C962, 2004.
29. Maniotis AJ, Chen CS, and Ingber DE. Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci USA 94: 849-854, 1997.
30. Martineau LC and Gardiner PF. Insight into skeletal muscle mechano-transduction: MAPK activation is quantitatively related to tension. J Appl Physiol 91: 693-702, 2001.
31. McNeil PL and Khakee R. Disruptions of muscle fiber plasma membranes. Role in exercise-induced damage. Am J Pathol 140: 1097-1109, 1992.
32. Minetti C, Bado M, Broda P, Sotgia F, Bruno C, Galbiati F, Volonte D, Lucania G, Pavan A, Bonilla E, Lisanti MP, and Cordone G. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol 160: 265-270, 2002.
33. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, and Zara F. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 18: 365-368, 1998.
34. Mobley BA and Eisenberg BR. Sizes of components in frog skeletal muscle measured by methods of stereology. J Gen Physiol 66: 31-45, 1975.
35. Nader GA and Esser KA. Intracellular signaling specificity in skeletal muscle in response to different modes of exercise. J Appl Physiol 90: 1936-1942, 2001.
36. Okamoto T, Schlegel A, Scherer PE, and Lisanti MP. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273: 5419-5422, 1998.
37. Palade GE. Fine structure of blood capillaries. J Appl Physiol 24: 1424-1436, 1953.
38. Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR, and Jo H. Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem 273: 32304-32311, 1998.
39. Petrof BJ. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 81: S162-S174, 2002.
40. Pol A, Calvo M, and Enrich C. Isolated endosomes from quiescent rat liver contain the signal transduction machinery. Differential distribution of activated Raf-1 and Mek in the endocytic compartment. FEBS Lett 441: 34-38, 1998.
41. Prescott L and Brightman MW. The sarcolemma of Aplysia smooth muscle in freeze-fracture preparations. Tissue Cell 8: 248-258, 1976.
42. Rando TA and Blau HM. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J Cell Biol 125: 1275-1287, 1994.
43. Raucher D and Sheetz MP. Characteristics of a membrane reservoir buffering membrane tension. Biophys J 77: 1992-2002, 1999.
44. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, and Minetti C. Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 261: 547-550, 1999.
45. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, and Anderson RG. Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682, 1992.
46. Rybin VO, Xu X, and Steinberg SF. Activated protein kinase C isoforms target to cardiomyocyte caveolae: stimulation of local protein phosphorylation. Circ Res 84: 980-988, 1999.
47. Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, and Lisanti NIP. Crowded little caves: structure and function of caveolae. Cell Signal 10: 457-463, 1998.
48. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, and Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269: 1435-1439, 1995.
49. Schnitzer JE, Oh P, Pinney E, and Allard J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol 127: 1217-1232, 1994.
50. Seger R and Krebs EG. The MAPK signaling cascade. FASEB J 9: 726-735, 1995.
51. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Biol Cell 19: 7289-7304, 1999.
52. Smythe GM, Eby JC, Disatnik MH, and Rando TA. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes. J Cell Sci 116: 4739-4749, 2003.
53. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, and Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
54. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, and Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165, 1996.
55. Sunada Y and Campbell KP. Dystrophin-glycoprotein complex: molecular organization and critical roles in skeletal muscle. Curr Opin Neurol 8: 379-384, 1995.
56. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, and Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 2255-2261, 1996.
57. Tatsumi R, Hattori A, Ikeuchi Y, Anderson JE, and Allen RE. Release of hepatocyte growth factor from mechanically stretched skeletal muscle satellite cells and role of pH and nitric oxide. Mol Biol Cell 13: 2909-2918, 2002.
58. Vaghy PL, Fang J, Wu W, and Vaghy LP. Increased caveolin-3 levels in mdx mouse muscles. FEBS Lett 431: 125-127, 1998.
59. Vandenburgh HH, Shansky J, Solerssi R, and Chromiak J. Mechanical stimulation of skeletal muscle increases prostaglandin F2 alpha production, cyclooxygenase activity, and cell growth by a pertussis toxin sensitive mechanism. J Cell Physiol 163: 285-294, 1995.
60. Volonte D, Peoples AJ, and Galbiati F. Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C. Mol Biol Cell 14: 4075-4088, 2003.
61. Way M and Parton RG. M-caveolin, a muscle-specific caveolin-related protein. FEBS Lett 378: 108-112, 1996.
62. Williams PE and Goldspink G. Changes in sarcomere length and physiological properties in immobilized muscle. J Anat 127: 459-468, 1978.
63. Williams PE and Goldspink G. The effect of immobilization on the longitudinal growth of striated muscle fibres. J Anat 116: 45-55, 1973.
64. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, and Lisanti MP. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277: 38988-38997, 2002.
65. Woodman SE, Sotgia F, Galbiati F, Minetti C, and Lisanti MP. Caveolinopathies: mutations in caveolin-3 cause four distinct autosomal dominant muscle diseases. Neurology 62: 538-543, 2004.
66. Yang S, Alnaqeeb M, Simpson H, and Goldspink G. Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 17: 487-495, 1996.
67. Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int 58: 193-205, 2000.